戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                           Frozen sections of capsulated and decapsulated bovine and human lenses were
2                                We engineered capsulated and unencapsulated isogenic mutant strains of
3 rmination, because s.c. inoculation with the capsulated bacillus forms also required toxin synthesis
4                                              Capsulated bacteria elicited IL-8 expression in polarize
5 to the pathogenesis of and immunity to other capsulated bacteria, and has contributed to the developm
6 rent directions of galvanotaxis of rough (or capsulate) bacteria and of smooth bacteria are explicabl
7 -derived macrophages was investigated with a capsulate case isolate and an isogenic Tn916-derived non
8 ained by subcloning outgrowths of cells from capsulated glomeruli.
9 in vitro against SP-A- and SP-B(N)-resistant capsulated Klebsiella pneumoniae (serotype K2) at neutra
10 ary processes but penetrates poorly into the capsulated lenses.
11 ic complexity of polysaccharide Ags in other capsulated microorganisms.
12 ctose led to attenuation of bone loss in the capsulated mixed infection and to intensification of bon
13 tion, Fn evaded phagocytosis, whereas in the capsulated mixed infection Pg displayed a greater capaci
14 d to intensification of bone loss in the non-capsulated mixed infection.
15 s were randomly selected for the placebo and capsulated mustard intervention; 9 of 11 subjects receiv
16                   After ingestion of 10 g of capsulated mustard or uncapsulated mustard or a capsulat
17 g fiber mat is significantly improved by the capsulated nanoparticles.
18       Mixed infections containing Fn and non-capsulated or capsulated strains of Pg were compared wit
19 ed a truncated or nonsialylated LOS, whether capsulated or not, were more sensitive to the inhibitory
20 enditure did not increase after ingestion of capsulated or uncapsulated mustard compared with placebo
21  of lysosomes with phagosomes containing the capsulate organism was significantly reduced 10 and 30 m
22  these vaccines, along with studies of other capsulated pathogens, should allow the rapid inclusion o
23                         Mixed infection with capsulated Pg augmented alveolar bone loss compared with
24 mpared with that of mixed infection with non-capsulated Pg.
25 sulated mustard or uncapsulated mustard or a capsulated placebo mixture, measurements of energy expen
26 nt may provide multitypic protection against capsulated pneumococci.
27  experimental nasopharyngeal colonization by capsulated S. pneumoniae of serotype 6B.
28 aperitoneal infection increased clearance of capsulated S. Typhi from the liver.
29  and decreased CR3-dependent clearance of Vi capsulated S. Typhi from the livers and spleens of mice.
30                                Comparison of capsulated S. Typhi with a noncapsulated mutant (Deltatv
31 del of fatal aspiration pneumonia by heavily capsulated serotype 3.
32 ly reduced when cells were infected with the capsulated serotype Typhi wild type.
33 he novel nanoparticles of DGL-PEG/dermorphin capsulated siRNA (OATP2B1) were applied to deliver siRNA
34 ive disulfide bond, while TET was physically capsulated spontaneously for the aim to suppress P-gp in
35                                          The capsulate strain was fourfold less adherent to the macro
36 y killed, although more rapid killing of the capsulate strain was observed over the first 3 h.
37 agocytosed by macrophage cell lines, whereas capsulated strains are resistant to phagocytosis.
38 s the adhesiveness of poorly adhering highly capsulated strains in vitro.
39 fections containing Fn and non-capsulated or capsulated strains of Pg were compared with the same inf
40                                 The ratio of capsulated to noncapsulated forms for group B and C stra
41 , and decreased efficacy in treatment of non-capsulated tumors limit its applicability.
42 have recently shown that numerous strains of capsulate (typeable) and acapsulate (non-typeable) H. in
43 sses with vibriocidal activity to strains of capsulated V. cholerae O139.
44  nonencapsulated, avirulent pneumococci into capsulated, virulent strains during infection in mice.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。